HPM Partners LLC Increases Position in CIGNA Co. (CI)
HPM Partners LLC boosted its holdings in shares of CIGNA Co. (NYSE:CI) by 8.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,256 shares of the health services provider’s stock after acquiring an additional 319 shares during the period. HPM Partners LLC’s holdings in CIGNA were worth $864,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Commerzbank Aktiengesellschaft FI grew its stake in CIGNA by 19.5% during the 4th quarter. Commerzbank Aktiengesellschaft FI now owns 1,667 shares of the health services provider’s stock valued at $339,000 after acquiring an additional 272 shares in the last quarter. Comerica Bank grew its stake in CIGNA by 0.4% during the 3rd quarter. Comerica Bank now owns 62,611 shares of the health services provider’s stock valued at $12,379,000 after acquiring an additional 274 shares in the last quarter. Investec Asset Management PTY Ltd grew its stake in CIGNA by 3.4% during the 3rd quarter. Investec Asset Management PTY Ltd now owns 8,865 shares of the health services provider’s stock valued at $1,645,000 after acquiring an additional 290 shares in the last quarter. Bfsg LLC grew its stake in CIGNA by 23.1% during the 4th quarter. Bfsg LLC now owns 1,642 shares of the health services provider’s stock valued at $333,000 after acquiring an additional 308 shares in the last quarter. Finally, Atria Investments LLC grew its stake in CIGNA by 9.6% during the 4th quarter. Atria Investments LLC now owns 3,580 shares of the health services provider’s stock valued at $727,000 after acquiring an additional 314 shares in the last quarter. 88.87% of the stock is owned by institutional investors.
CI has been the subject of several analyst reports. Zacks Investment Research raised shares of CIGNA from a “hold” rating to a “buy” rating and set a $231.00 price target for the company in a research note on Friday, December 22nd. Morgan Stanley increased their price target on shares of CIGNA to $255.00 and gave the company an “overweight” rating in a research note on Friday, February 2nd. Oppenheimer increased their price target on shares of CIGNA to $237.00 and gave the company an “outperform” rating in a research note on Friday, February 2nd. Goldman Sachs Group initiated coverage on shares of CIGNA in a research note on Wednesday, January 3rd. They issued a “neutral” rating and a $247.00 price target for the company. Finally, ValuEngine raised shares of CIGNA from a “hold” rating to a “buy” rating in a research note on Sunday, December 31st. Four research analysts have rated the stock with a hold rating, sixteen have issued a buy rating and one has given a strong buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $210.37.
CIGNA Co. (NYSE CI) opened at $164.39 on Wednesday. The company has a quick ratio of 0.37, a current ratio of 0.37 and a debt-to-equity ratio of 0.38. CIGNA Co. has a fifty-two week low of $143.85 and a fifty-two week high of $227.13. The company has a market cap of $40,635.48, a P/E ratio of 16.01, a PEG ratio of 1.01 and a beta of 0.51.
CIGNA (NYSE:CI) last issued its quarterly earnings data on Thursday, February 1st. The health services provider reported $1.94 EPS for the quarter, topping the consensus estimate of $1.87 by $0.07. CIGNA had a net margin of 5.38% and a return on equity of 18.84%. The firm had revenue of $10.53 billion for the quarter, compared to analyst estimates of $10.28 billion. During the same period in the prior year, the business posted $1.87 EPS. The business’s revenue for the quarter was up 5.9% compared to the same quarter last year. research analysts anticipate that CIGNA Co. will post 12.9 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 10th. Stockholders of record on Monday, March 12th will be issued a $0.04 dividend. The ex-dividend date of this dividend is Friday, March 9th. This represents a $0.16 annualized dividend and a dividend yield of 0.10%. CIGNA’s dividend payout ratio is currently 0.46%.
COPYRIGHT VIOLATION NOTICE: “HPM Partners LLC Increases Position in CIGNA Co. (CI)” was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece of content can be accessed at https://www.thecerbatgem.com/2018/03/14/hpm-partners-llc-increases-position-in-cigna-co-ci.html.
CIGNA Company Profile
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CIGNA Co. (NYSE:CI).
Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.